From ASCO to ESMO GI: Key Updates in GI Oncology
Jun 30, 2026
View online
Top Trials to Watch at ESMO GI 2026
Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet
ASCO 2026 Highlights by GI Cancers Alliance: What’s New in Stomach Cancer Care
Vopimetostat Plus Daraxonrasib Shows 92% ORR in MTAP-Deleted, RAS-Mutant mPDAC
Eileen O’Reilly Receives Hope Through Compassion Award for Pancreatic Cancer Leadership
10 Must-Read Posts In GI Oncology This Week
PRODIGE 81-TRIPLET-HCC: Ipilimumab Added to Atezolizumab and Bevacizumab in Advanced HCC
Attending ESMO GI 2026? Join the OncoDaily Ambassador Team
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
